Status:
RECRUITING
Tongyuan Acupuncture on Consciousness Disorder After Stroke
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Stroke
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Stroke is a common and frequently-occurring disease in the world. Patients with stroke often have sequelae and functional disorders of varying degrees, among which the disturbance of consciousness has...
Detailed Description
This study was a randomized, placebo-controlled, single-blind study. Approximately 174 people will participate in the study at the medical facility. Patients with post-stroke consciousness disorder ho...
Eligibility Criteria
Inclusion
- sign the informed consent voluntarily;
- met the above diagnostic criteria, and the GCS score was between 3 and 9 (the score was scored by a rehabilitation physician, and the patient had not used sedatives or anesthetics on the day of the score);
- The patient's condition is stable, vital signs are stable, and the onset time of consciousness disturbance caused by stroke is confirmed to be less than 6 months;
- Cerebral infarction or cerebral hemorrhage confirmed by clinical and auxiliary examination is the only factor causing consciousness disorder, excluding other diseases caused consciousness disorder patients;
- those aged between 18 and 85;
- Family members or authorized principals know and sign informed consent;
- did not enter other clinical studies at the same time.
Exclusion
- People with consciousness impairment mainly due to changes in consciousness content or special types;
- confirmed carbon monoxide poisoning, brain tumor, brain trauma, brain parasitic disease, metabolic disorders;
- Patients with severe primary diseases of liver, kidney, blood system, endocrine system and other diseases with poor prognosis, mental diseases;
- have upper gastrointestinal hemorrhage, secondary epilepsy and other serious complications;
- Those who have venous thrombosis and are currently on anticoagulant therapy;
- patients judged by the investigator to be unsuitable for participation in this trial;
Key Trial Info
Start Date :
March 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT06202833
Start Date
March 20 2024
End Date
December 31 2025
Last Update
March 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
YI WEI
Guangzhou, Guangdong, China, 510515